Low-Dose
Lung CT in Bali: Early Cancer Screening for Executive Smokers &
Ex-Smokers
A low-dose CT (LDCT) scan of the chest is the only
lung-cancer screening test proven to save lives in high-risk people —
chiefly current and former heavy smokers — by finding tumours while they
are small and treatable, and it can be arranged discreetly within an
executive check-up in Bali. For a leader with a smoking
history, this is one of the highest-value screening decisions available,
because lung cancer is usually silent until it is advanced, and early
detection changes the outcome dramatically.
I am Dr. Anneke Wijaya, a preventive-medicine physician who has
designed executive screening across Jakarta, Singapore, and Bali. Lung
screening is a test I recommend carefully and selectively — it is
enormously beneficial for the right person, and unnecessary for the
wrong one. This guide explains where the line sits.
Why lung cancer is different
Lung cancer remains one of the leading causes of cancer death
worldwide, largely because it typically produces no symptoms until it
has grown or spread. By the time a persistent cough, weight loss, or
breathlessness appears, the disease is often advanced and far harder to
treat. The entire logic of LDCT screening is to intervene before that
point — to catch a small, curable nodule during a window when the person
feels completely well.
Executive life can compound this risk in subtle ways: a smoking
history from earlier decades that is easy to minimise, years of client
entertaining, and exposure during travel. The critical variable is not
current habit but cumulative exposure — measured in “pack-years.”
What a low-dose CT scan
involves
An LDCT is a specialised chest CT that uses a fraction of the
radiation of a standard diagnostic CT — hence “low-dose.” You lie on a
table that passes briefly through the scanner ring while holding your
breath for a few seconds; there is no injection and the scan takes only
minutes. It produces detailed cross-sectional images of the lungs,
capable of detecting nodules far smaller than a conventional chest X-ray
could ever show.
The radiation dose, while low, is not zero, which is precisely why
LDCT is reserved for those at genuinely elevated risk rather than
offered to everyone. For the right candidate, the benefit clearly
outweighs the small radiation exposure; for a lifelong non-smoker at
average risk, it generally does not.
Who benefits from lung
screening
Major guidelines — including those referenced by the American
Cancer Society — recommend annual LDCT screening for people who meet
all of the following: a substantial smoking history (commonly defined as
at least 20 pack-years), current smoking or having quit within the past
15 years, and an age typically in the 50–80 range. In practice, for the
executive population I focus on:
- Current smokers with a meaningful cumulative
history. - Former heavy smokers, especially those who quit
within the last decade and may wrongly assume the risk vanished with the
habit. - Those with occupational or family risk factors
layered on top of any smoking history.
Screening is not recommended for lifelong non-smokers at average
risk, where the small radiation dose and the chance of false alarms
outweigh the benefit.
Handling nodules without
panic
The most important thing to understand before screening is that
finding a small nodule is common and usually not cancer. Many
nodules are benign scars or old infections. This is why LDCT results are
managed through a structured protocol: most small nodules are simply
watched with a follow-up scan to confirm they are stable, and only a
minority require further investigation. Knowing this in advance turns an
anxious “spot on the lung” into a routine, planned next step rather than
a crisis.
Because lung screening sits within a broader early-detection
strategy, it is best understood alongside the wider panel in our comprehensive executive health
check-up and our detailed executive cancer
screening guide. For those weighing whole-body imaging more
generally, our take on the full-body MRI
question explains why targeted, evidence-based scans usually beat
scanning everything at once.
Understanding
the trade-offs before you screen
Good screening decisions are made with eyes open. LDCT’s real benefit
— fewer deaths from lung cancer in high-risk people — is well
established, but it comes with trade-offs worth understanding in
advance. False alarms occur: a benign nodule can prompt follow-up scans
and, occasionally, an unnecessary procedure. There is also a small
radiation dose with each scan, and the phenomenon of “overdiagnosis,”
where a slow-growing finding that would never have caused harm is
treated anyway. For the right candidate — a current or recent
heavy smoker in the eligible age band — the balance tips clearly toward
benefit, which is why guidelines endorse it for that group and not for
everyone. Part of the value of a physician-led screening is talking this
through honestly, so you choose the scan for informed reasons rather
than reflexive reassurance.
Screening is only half the
strategy
For any current smoker, the single most powerful health intervention
is not the scan but stopping smoking — and the two work best together.
The years after quitting steadily lower lung-cancer risk, and screening
bridges the period when residual risk remains elevated. If you are a
current smoker considering an LDCT, treat the appointment as a moment to
also discuss cessation support with the physician; the combination of
quitting plus targeted screening does far more than either alone.
Ex-smokers, meanwhile, should not assume the risk vanished with the
habit: it declines but persists for years, which is precisely why recent
quitters remain eligible for screening.
Reading results calmly
An LDCT result — whether clear, or showing a nodule to monitor —
belongs in a physician consultation, read against your smoking history
and overall risk. A nodule report is not a diagnosis; it is the start of
a defined pathway that most often ends in reassurance. The purpose of
screening is to move lung-cancer risk from invisible to caught-early,
when treatment works best.
Medical disclaimer: This content is for general
information only and is not a substitute for individualised medical
advice, diagnosis, or treatment. Lung-cancer screening carries both
benefits and small risks, and eligibility depends on personal smoking
history and age. Never make screening or treatment decisions without
consulting a qualified physician.
Arrange lung screening in
Bali
If you have a smoking history and want low-dose lung CT considered
within a private, same-day executive check-up, our concierge team can
arrange it discreetly. See the full experience on the Bali
Executive Checkup homepage, then arrange your private executive
check-up here. Want to check whether you qualify first? Message our
concierge on WhatsApp at wa.me/6281139414563.
Related reading: Executive Cancer
Screening in Bali: What to Know · Full-Body MRI for
Executives in Bali: Worth It? · What an
Executive Health Check Includes in Bali
Written and clinically reviewed by Dr. Anneke Wijaya, MD
(Universitas Indonesia), MSc Occupational & Travel Medicine, Diploma
in Preventive Cardiology, Medical Advisor & Preventive Medicine Lead
at Bali Executive Checkup.